Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Cytokine|May 25, 2006
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J miceXuemei Li, Xizhong Cui, Yan Li, et al.
Expert Opinion on Investigational Drugs|June 27, 2009
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvateXuemei Li, Junwu Su, Xizhong Cui, et al.
Biologics : Targets & Therapy|September 24, 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studiesLaith Altaweel, Daniel Sweeney, Xizhong Cui, et al.
Journal of Obesity|March 27, 2020
The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-AnalysisWanying Xu, Dominique Pepper, Junfeng Sun, et al.
Intensive Care Medicine Experimental|February 6, 2020
Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysisLindsay M Busch, Junfeng Sun, Xizhong Cui, et al.
Toxins|January 16, 2021
A Review of the Efficacy of FDA-Approved <i>B. anthracis</i> Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical ModelsZoe Couse, Xizhong Cui, Yan Li, et al.
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumesPeter Q Eichacker, Eric P Gerstenberger, Steven M Banks, et al.
Expert Opinion on Investigational Drugs|October 4, 2011
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathPing Qiu, Xizhong Cui, Amisha Barochia, et al.
Critical Care Medicine|July 27, 2013
Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysisPing Qiu, Xizhong Cui, Junfeng Sun, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Cytokine|May 25, 2006
Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J miceXuemei Li, Xizhong Cui, Yan Li, et al.
Expert Opinion on Investigational Drugs|June 27, 2009
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvateXuemei Li, Junwu Su, Xizhong Cui, et al.
Biologics : Targets & Therapy|September 24, 2009
Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studiesLaith Altaweel, Daniel Sweeney, Xizhong Cui, et al.
Journal of Obesity|March 27, 2020
The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-AnalysisWanying Xu, Dominique Pepper, Junfeng Sun, et al.
Intensive Care Medicine Experimental|February 6, 2020
Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysisLindsay M Busch, Junfeng Sun, Xizhong Cui, et al.
Toxins|January 16, 2021
A Review of the Efficacy of FDA-Approved <i>B. anthracis</i> Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical ModelsZoe Couse, Xizhong Cui, Yan Li, et al.
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumesPeter Q Eichacker, Eric P Gerstenberger, Steven M Banks, et al.
Expert Opinion on Investigational Drugs|October 4, 2011
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathPing Qiu, Xizhong Cui, Amisha Barochia, et al.
Critical Care Medicine|July 27, 2013
Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysisPing Qiu, Xizhong Cui, Junfeng Sun, et al.
Pageof 13